Search - tctmd.com

Displaying 261 - 280 of 700

Sort: Relevancy | Date

News Industry News

Boston Scientific Receives FDA Approval For SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System

October 05, 2015

News Daily News

新型生物可吸收聚合物 SES 的良好结局持续 2 年

Yael L. Maxwell

October 02, 2015

News Daily News

Good Outcomes of Novel Bioresorbable-Polymer SES Persist at 2 Years

Yael L. Maxwell

October 02, 2015

News Daily News

OPTIMAX: First-in-Human Results Promising for Biocompatible Cobalt-Chromium Stent

Yael L. Maxwell

September 14, 2015

News Daily News

OPTIMAX：生物相容性钴铬支架的首例人类结果前景看好

Yael L. Maxwell

September 14, 2015

News Conference News ESC 2015

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

September 09, 2015

News Conference News ESC 2015

EXAMINATION: STEMI Patients Fare Better at 5 Years With EES vs BMS

Caitlin E. Cox

September 02, 2015

News Conference News ESC 2015

ABSORB Trials Pit BRS Against Second-Generation DES

Caitlin E. Cox

September 02, 2015

News Daily News

SES 骨折与长期结局恶化相关

August 31, 2015

News Daily News

SES Fracture Linked to Worse Long-term Outcomes

August 31, 2015

News Daily News

登记研究表明 Absorb BVS 治疗所有糖尿病患者的效果与 DES 相当

August 27, 2015

News Daily News

Registry Study Suggests Absorb BVS Matches DES in Diabetic All-Comers

August 27, 2015

News Daily News

采用第二代 DES 的双支架策略在治疗分叉病变时无劣势

Yael L. Maxwell

August 26, 2015

News Daily News

No Disadvantage for 2-Stent Strategy in Bifurcation Lesions With Second-Generation DES

Yael L. Maxwell

August 26, 2015

News Daily News

ILUMIEN I 发布：OCT 能够影响 PCI 策略

L.A. McKeown

August 17, 2015

News Daily News

ILUMIEN I Published: OCT Can Affect PCI Strategy

L.A. McKeown

August 17, 2015

News Daily News

COMPARE:5 年时 EES 的疗效仍优于 PES

Salynn Boyles

July 30, 2015

News Daily News

COMPARE: EES Maintains Advantage Over PES at 5 Years

Salynn Boyles

July 30, 2015

News Daily News

斑块消退证据对于联合使用他汀类药物与依泽替米贝的病例提出了支持

L.A. McKeown

July 29, 2015

News Daily News

Evidence of Plaque Regression Bolsters Case for Combining Ezetimibe With Statin

L.A. McKeown

July 29, 2015

Advertisement

Boston Scientific Receives FDA Approval For SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System

新型生物可吸收聚合物 SES 的良好结局持续 2 年

Good Outcomes of Novel Bioresorbable-Polymer SES Persist at 2 Years

OPTIMAX: First-in-Human Results Promising for Biocompatible Cobalt-Chromium Stent

OPTIMAX：生物相容性钴铬支架的首例人类结果前景看好

ESC Congress 2015: Presentations Sift Clinical Wheat From Chaff

EXAMINATION: STEMI Patients Fare Better at 5 Years With EES vs BMS

ABSORB Trials Pit BRS Against Second-Generation DES

SES 骨折与长期结局恶化相关

SES Fracture Linked to Worse Long-term Outcomes

登记研究表明 Absorb BVS 治疗所有糖尿病患者的效果与 DES 相当

Registry Study Suggests Absorb BVS Matches DES in Diabetic All-Comers

采用第二代 DES 的双支架策略在治疗分叉病变时无劣势

No Disadvantage for 2-Stent Strategy in Bifurcation Lesions With Second-Generation DES

ILUMIEN I 发布：OCT 能够影响 PCI 策略

ILUMIEN I Published: OCT Can Affect PCI Strategy

COMPARE:5 年时 EES 的疗效仍优于 PES

COMPARE: EES Maintains Advantage Over PES at 5 Years

斑块消退证据对于联合使用他汀类药物与依泽替米贝的病例提出了支持

Evidence of Plaque Regression Bolsters Case for Combining Ezetimibe With Statin

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content